Showing results (11-20 of 136) with videos related to
Sort By:
Pageof 14
Respiratory Medicine Case Reports|March 1, 2018
Successful osimertinib rechallenge after osimertinib-induced pneumonitis in a patient with lung adenocarcinomaShingo Satoh, Takayuki Shiroyama, Motohiro Tamiya, et al.Journal of Thoracic Disease|February 24, 2016
Chemotherapy for patients with advanced lung cancer receiving long-term oxygen therapyManabu Hayama, Hidekazu Suzuki, Takayuki Shiroyama, et al.Asia-Pacific Journal of Clinical Oncology|December 23, 2016
Afatinib successfully treated leptomeningeal metastasis during erlotinib treatment in a patient with EGFR-mutant (Exon18:G719S) lung adenocarcinoma as a second-line chemotherapyMotohiro Tamiya, Takayuki Shiroyama, Takashi Nishihara, et al.Journal of Medical Virology|October 28, 2021
Prolonged corticosteroid therapy and cytomegalovirus infection in patients with severe COVID-19Yuji Yamamoto, Takayuki Shiroyama, Haruhiko Hirata, et al.Clinical Case Reports|January 25, 2023
Secondary subcutaneous abscess due to mixed infections by Peptoniphilus olsenii and Gleimia europaea after COVID-19Yuji Yamamoto, Takayuki Shiroyama, Haruhiko Hirata, et al.Internal Medicine (Tokyo, Japan)|November 17, 2015
Nanoparticle Albumin-bound Paclitaxel+Carboplatin Therapy for Small Cell Lung Cancer Combined with Squamous Cell Carcinoma and Interstitial Lung DiseaseYuichiro Azuma, Motohiro Tamiya, Takayuki Shiroyama, et al.Respirology (Carlton, Vic.)|April 17, 2013
Diagnostic yield of combined bronchoscopy and endobronchial ultrasonography, under LungPoint guidance for small peripheral pulmonary lesionsMotohiro Tamiya, Norio Okamoto, Shinji Sasada, et al.Respiratory Medicine Case Reports|November 30, 2016
Successful retreatment with osimertinib after osimertinib-induced acute pulmonary embolism in a patient with lung adenocarcinoma: A case reportTakayuki Shiroyama, Manabu Hayama, Shingo Satoh, et al.Chinese Journal of Cancer|December 15, 2012
The relationship between tyrosine kinase inhibitor therapy and overall survival in patients with non-small cell lung cancer carrying EGFR mutationsHidekazu Suzuki, Tomonori Hirashima, Norio Okamoto, et al.Scientific Reports|October 18, 2024
MicroRNA-130a-3p regulates osimertinib resistance by targeting runt-related transcription factor 3 in lung adenocarcinomaTakuya Shintani, Yu-Ting Shun, Yuji Toyozumi, et al.Pageof 14